BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 1 calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:5433a49d-867a-42eb-ba01-09a7454baabb
DTSTAMP:20250617T145719
DTSTART:20250922T100000
DTEND:20250922T110000
SUMMARY:Comms Y1 meet the team
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:f99380eb-895f-4e0b-9528-4afb0ad40d07
DTSTAMP:20250617T145719
DTSTART:20250922T110000
DTEND:20250922T120000
SUMMARY:Comms Y1 meet the team
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:f739d1a7-bbb3-408d-8500-963c2ff1774e
DTSTAMP:20250617T145719
DTSTART:20250925T100000
DTEND:20250925T110000
SUMMARY:Labcoat collection (9-10)
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:0034f35c-5467-444c-83b7-7e3a3213c484
DTSTAMP:20250617T145719
DTSTART:20250926T100000
DTEND:20250926T110000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:4a041d7b-e539-4b59-9068-73dd2e57b716
DTSTAMP:20250617T145719
DTSTART:20250926T110000
DTEND:20250926T120000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:d945fbd9-987c-4e1d-8b82-cf248cecd7ba
DTSTAMP:20250617T145719
DTSTART:20250926T120000
DTEND:20250926T130000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:3600147a-e745-4966-be81-d2ddf4e62aac
DTSTAMP:20250617T145719
DTSTART:20250926T140000
DTEND:20250926T150000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:5c92eb93-c7c1-45d8-b9e9-5d3aab7b8c60
DTSTAMP:20250617T145719
DTSTART:20250926T150000
DTEND:20250926T160000
SUMMARY:Comms Course specific induction
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:44474e6e-69fd-4646-9a2d-474bee24478a
DTSTAMP:20250617T145719
DTSTART:20250929T110000
DTEND:20250929T120000
SUMMARY:Skills Introduction to module
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ae16f4f2-2336-4c92-8eea-645a160701cd
DTSTAMP:20250617T145719
DTSTART:20250929T120000
DTEND:20250929T130000
SUMMARY:Introduction to FS and pharmacodynamics
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:cd33c87b-4f99-4468-ab81-57e59dc608c1
DTSTAMP:20250617T145719
DTSTART:20250929T140000
DTEND:20250929T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f650b1e2-c4af-460d-8675-976597d5394c
DTSTAMP:20250617T145719
DTSTART:20250929T150000
DTEND:20250929T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2c186010-2ecf-4fd5-b7d4-e0e2debbe69f
DTSTAMP:20250617T145719
DTSTART:20250930T100000
DTEND:20250930T110000
SUMMARY:FS 1.1 The Body: Introduction
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:7df8b04b-e582-4ddf-a1df-b2c09ee534bd
DTSTAMP:20250617T145719
DTSTART:20250930T110000
DTEND:20250930T120000
SUMMARY:FS 1.2 The Body: Tissues
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:13d4f124-ed5f-48dd-aad3-32dfd3c2dc79
DTSTAMP:20250617T145719
DTSTART:20250930T120000
DTEND:20250930T130000
SUMMARY:FS 1.3 The Body: Cells and Molecules
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:f079539f-f374-4b32-830d-42de8f4f768e
DTSTAMP:20250617T145719
DTSTART:20250930T140000
DTEND:20250930T150000
SUMMARY:Skills 1.1 Numeracy
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:133f1ee7-52b2-47c9-b812-931a788f5485
DTSTAMP:20250617T145719
DTSTART:20250930T150000
DTEND:20250930T160000
SUMMARY:Skills 1.1 Numeracy
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b0736c99-0d21-4e5f-aff3-857331e5a02c
DTSTAMP:20250617T145719
DTSTART:20251002T110000
DTEND:20251002T120000
SUMMARY:PD 1.1 Fundamentals - Part I
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:7154c2f5-d17f-4435-b666-cb7478460703
DTSTAMP:20250617T145719
DTSTART:20251002T120000
DTEND:20251002T130000
SUMMARY:PD 1.2 Fundamentals - Part I
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:bc566b82-4c63-4845-a2e7-78b4b76d88ee
DTSTAMP:20250617T145719
DTSTART:20251002T140000
DTEND:20251002T150000
SUMMARY:DS 1.1 Introduction to data and statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:03b44d70-0918-420e-9f67-8a50223a53ec
DTSTAMP:20250617T145719
DTSTART:20251002T150000
DTEND:20251002T160000
SUMMARY:DS Introduction to excel 3-4.30
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:dd021e38-5eb6-4e34-ace9-c1cfc4f689ab
DTSTAMP:20250617T145719
DTSTART:20251002T160000
DTEND:20251002T170000
SUMMARY:DS Introduction to excel 3-4.30
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:8fac37b3-d039-4c02-b234-00c222eb428a
DTSTAMP:20250617T145719
DTSTART:20251003T140000
DTEND:20251003T150000
SUMMARY:DH 1.1 Introduction to drugs in healthcare
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:8947761e-248f-44bc-84e4-026c4776c646
DTSTAMP:20250617T145719
DTSTART:20251003T150000
DTEND:20251003T160000
SUMMARY:DH 1.1 Introduction to drugs in healthcare
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:186199c7-a692-4a92-9cfe-5192567f79e6
DTSTAMP:20250617T145719
DTSTART:20251006T100000
DTEND:20251006T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8cc4c1c0-0955-45c2-becd-1c3af232e2ed
DTSTAMP:20250617T145719
DTSTART:20251006T110000
DTEND:20251006T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ef38d47f-92a3-41f3-af4d-f0fb4d934d70
DTSTAMP:20250617T145719
DTSTART:20251006T120000
DTEND:20251006T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:c8e2e386-7019-46e0-aab7-90416b42ec2c
DTSTAMP:20250617T145719
DTSTART:20251006T140000
DTEND:20251006T150000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:abbeb6dc-e586-4172-8e45-33cab7857793
DTSTAMP:20250617T145719
DTSTART:20251006T150000
DTEND:20251006T160000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e91d6e0c-9658-4ebb-b231-bd6ab0a0ac42
DTSTAMP:20250617T145719
DTSTART:20251006T160000
DTEND:20251006T170000
SUMMARY:Skills 1.2  Introduction to basic lab skills
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:11b65122-fd0f-41a7-9caf-50e18593a39d
DTSTAMP:20250617T145719
DTSTART:20251007T110000
DTEND:20251007T120000
SUMMARY:FS 1.4 The Body: Control and Regulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:83d3b533-9ed0-4554-9ab2-e4814a274705
DTSTAMP:20250617T145719
DTSTART:20251007T120000
DTEND:20251007T130000
SUMMARY:FS 1.5 The Body: Environment and Exchange
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:efdeb21d-cd5c-475d-bd57-532da3decdb6
DTSTAMP:20250617T145719
DTSTART:20251007T140000
DTEND:20251007T150000
SUMMARY:FS 1.6 The Body: Growth and Energy
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:4f9aabf5-bfd3-4ed8-9c1d-f658c849eac4
DTSTAMP:20250617T145719
DTSTART:20251009T110000
DTEND:20251009T120000
SUMMARY:PD 1.3 Fundamentals: Part II
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:f55c3fa8-fe24-47c6-9e81-9f287f3b4e1a
DTSTAMP:20250617T145719
DTSTART:20251009T120000
DTEND:20251009T130000
SUMMARY:PD 1.4 Fundamentals: Part II
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:ec5da4cf-073c-49c8-8da9-785a53483b7b
DTSTAMP:20250617T145719
DTSTART:20251009T140000
DTEND:20251009T150000
SUMMARY:DS 1.2 Types of data and how to describe them
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:15a0c92d-75d3-4943-a04f-e3e1729c8ef7
DTSTAMP:20250617T145719
DTSTART:20251009T150000
DTEND:20251009T160000
SUMMARY:DS Excel skills 2
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:2d574498-b804-4d80-80d2-ecdda0e05eb8
DTSTAMP:20250617T145719
DTSTART:20251009T160000
DTEND:20251009T170000
SUMMARY:DS Excel skills 2
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:55ae4ffc-37f8-42fa-b158-92f869031ee4
DTSTAMP:20250617T145719
DTSTART:20251010T100000
DTEND:20251010T110000
SUMMARY:DD Introduction to drug development
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:b7e376aa-1462-4c69-a6bd-d7017938ab82
DTSTAMP:20250617T145719
DTSTART:20251010T110000
DTEND:20251010T120000
SUMMARY:DD Introduction to biomedical research and bias
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:a3ffa977-d210-432f-a100-3ecae52ad0de
DTSTAMP:20250617T145719
DTSTART:20251010T120000
DTEND:20251010T130000
SUMMARY:Comms Introduction to the library
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9c753d11-b1e0-4577-bcba-72b8093eb741
DTSTAMP:20250617T145719
DTSTART:20251010T140000
DTEND:20251010T150000
SUMMARY:PK Introduction to pharmacokinetics
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:360b9368-5efc-46b9-8c52-9df0ec10f2b3
DTSTAMP:20250617T145719
DTSTART:20251010T150000
DTEND:20251010T160000
SUMMARY:Skills WINDEC and hand hygiene [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e85779a9-c3c5-4882-a6cd-e545d92a5659
DTSTAMP:20250617T145719
DTSTART:20251013T100000
DTEND:20251013T110000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d242a65f-dc2c-4667-a302-6908abfa31e7
DTSTAMP:20250617T145719
DTSTART:20251013T110000
DTEND:20251013T120000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2caf7628-880a-474a-b4b6-091b48a0a050
DTSTAMP:20250617T145719
DTSTART:20251013T120000
DTEND:20251013T130000
SUMMARY:Skills WINDEC and hand hygiene
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:083973b1-7014-4ce8-921a-cb6e6f664b3f
DTSTAMP:20250617T145719
DTSTART:20251013T140000
DTEND:20251013T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:76207339-6193-4114-9f33-5afed799124b
DTSTAMP:20250617T145719
DTSTART:20251013T150000
DTEND:20251013T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d2649d34-4377-45a3-9c78-6e69ea6077b9
DTSTAMP:20250617T145719
DTSTART:20251014T100000
DTEND:20251014T110000
SUMMARY:FS 1.7 Chemical Mediators
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:1e114713-f7d4-41dc-a976-f5b727effa14
DTSTAMP:20250617T145719
DTSTART:20251014T110000
DTEND:20251014T120000
SUMMARY:FS 1.8 Cell division and fate
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:8d2c847a-631d-4b6c-8595-417bc369adeb
DTSTAMP:20250617T145719
DTSTART:20251014T120000
DTEND:20251014T130000
SUMMARY:FS 1.9 DNA to Gene Expression
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:bde07cfe-ac01-4a92-87a4-17e900620406
DTSTAMP:20250617T145719
DTSTART:20251015T100000
DTEND:20251015T110000
SUMMARY:WEC Pharmacy visits - Group 1 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fce06cd7-f6f9-4e4f-9c66-909a41047252
DTSTAMP:20250617T145719
DTSTART:20251015T110000
DTEND:20251015T120000
SUMMARY:WEC Pharmacy visits - Group 1 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2172b013-2fce-4b98-b03f-28d0f25ffd62
DTSTAMP:20250617T145719
DTSTART:20251016T100000
DTEND:20251016T110000
SUMMARY:PK 1.1 Drug formulation
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:7e433b87-c06a-476b-917a-5ae307a8dc95
DTSTAMP:20250617T145719
DTSTART:20251016T110000
DTEND:20251016T120000
SUMMARY:WEC Introduction to careers
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9a225469-78fc-4c44-9804-992af17c6087
DTSTAMP:20250617T145719
DTSTART:20251016T120000
DTEND:20251016T130000
SUMMARY:WEC Introduction to careers
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:94ed1448-0f12-4aab-a48c-dc0edab69a4c
DTSTAMP:20250617T145719
DTSTART:20251016T140000
DTEND:20251016T150000
SUMMARY:PD 1.5 Fundamentals -Part 3
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:f8d7fe98-57d3-43cc-a0cf-bc4d5ccfb1fc
DTSTAMP:20250617T145719
DTSTART:20251016T150000
DTEND:20251016T160000
SUMMARY:PD 1.6 Fundamentals -Part 3
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:f031c76b-d15d-4209-867e-206323fa30e4
DTSTAMP:20250617T145719
DTSTART:20251017T110000
DTEND:20251017T120000
SUMMARY:FS recap Key Concepts
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:0df08682-a238-40fb-8bce-d0c89d15221c
DTSTAMP:20250617T145719
DTSTART:20251017T120000
DTEND:20251017T130000
SUMMARY:FS recap Key Concepts
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:f89eab5d-6af2-4ec8-895e-8122dbb2b217
DTSTAMP:20250617T145719
DTSTART:20251017T140000
DTEND:20251017T150000
SUMMARY:DH 1.2  How do healthcare professionals decide which medicines a patient needs?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:d04901d7-4503-4211-ab9e-e99cba7df28e
DTSTAMP:20250617T145719
DTSTART:20251017T150000
DTEND:20251017T160000
SUMMARY:DH 1.2  How do healthcare professionals decide which medicines a patient needs?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:8c6a3257-a175-4be0-b845-bc0061d38ee7
DTSTAMP:20250617T145719
DTSTART:20251020T100000
DTEND:20251020T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:40d006b0-a062-4d88-91b7-aeb47474cc9b
DTSTAMP:20250617T145719
DTSTART:20251020T110000
DTEND:20251020T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:939e394c-f011-49be-baa0-39daf8c1e96a
DTSTAMP:20250617T145719
DTSTART:20251020T120000
DTEND:20251020T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:101e7696-0b8e-4643-975c-a24705a90bfd
DTSTAMP:20250617T145719
DTSTART:20251020T140000
DTEND:20251020T150000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9daa107d-f19a-4886-b52d-a7fca9e1925f
DTSTAMP:20250617T145719
DTSTART:20251020T150000
DTEND:20251020T160000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:95cc064c-b80c-483d-abdd-5b368b152724
DTSTAMP:20250617T145719
DTSTART:20251020T160000
DTEND:20251020T170000
SUMMARY:Skills 1.3  Spectrophotometry 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5cf959da-52c6-4e00-b92d-00e35c862ba2
DTSTAMP:20250617T145719
DTSTART:20251021T110000
DTEND:20251021T120000
SUMMARY:DD Target selection and validation
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:6520b565-9aed-445f-9f6c-e9c1090c037e
DTSTAMP:20250617T145719
DTSTART:20251021T120000
DTEND:20251021T130000
SUMMARY:DD  Lead generation and optimisation
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:e6b608ad-4d45-4dc1-8989-ea9e7186d332
DTSTAMP:20250617T145719
DTSTART:20251021T140000
DTEND:20251021T150000
SUMMARY:FS 1.10 G protein coupled receptors
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:44954439-e592-42ed-a2a1-35f89983dc8f
DTSTAMP:20250617T145719
DTSTART:20251021T150000
DTEND:20251021T160000
SUMMARY:FS 1.11 Membrane Potentials and Action Potentials
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:fccf0366-d04c-4dd5-9b7f-fee6b57d793c
DTSTAMP:20250617T145719
DTSTART:20251023T100000
DTEND:20251023T110000
SUMMARY:Skills Routes of administration [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:00b91cc9-2173-4bee-8354-4fa1ffa7c25b
DTSTAMP:20250617T145719
DTSTART:20251023T110000
DTEND:20251023T120000
SUMMARY:FS 1.12 Autonomic nervous system 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:df178e31-840f-4d5c-bd15-836ccf33082e
DTSTAMP:20250617T145719
DTSTART:20251023T120000
DTEND:20251023T130000
SUMMARY:FS 1.13 Autonomic nervous system 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:e3853154-7abf-4597-82a7-55de3f2e51ca
DTSTAMP:20250617T145719
DTSTART:20251023T140000
DTEND:20251023T150000
SUMMARY:DS 1.3  Introduction to clinical study design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:c0d97413-f333-4fb2-a01c-87dcaa5b6013
DTSTAMP:20250617T145719
DTSTART:20251023T150000
DTEND:20251023T160000
SUMMARY:DS Spreadsheet design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:48c115ad-43f2-40b2-8f88-8c4b6fe604c2
DTSTAMP:20250617T145719
DTSTART:20251023T160000
DTEND:20251023T170000
SUMMARY:DS Spreadsheet design
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:4bdd3412-dd71-4349-82c8-7fba537500ec
DTSTAMP:20250617T145719
DTSTART:20251024T110000
DTEND:20251024T120000
SUMMARY:PK 1.2 Enteral administration
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:298de749-ab05-4dbe-85ad-e945875c21d4
DTSTAMP:20250617T145719
DTSTART:20251024T120000
DTEND:20251024T130000
SUMMARY:PK 1.3 Parenteral administration
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:3f1306dc-aec3-48c9-9eef-ce5ac0702921
DTSTAMP:20250617T145719
DTSTART:20251024T130000
DTEND:20251024T140000
SUMMARY:WEC Lunch and learn
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:de173b95-fec5-4c2b-a9b1-04c49dac2d9b
DTSTAMP:20250617T145719
DTSTART:20251024T140000
DTEND:20251024T150000
SUMMARY:PD 1.7 Drugs targeting ANS -Part 1:  Sympathetic/Parasympathetic GPCRs
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:65fc81cf-65f9-464d-8a71-fa8e6a2667f1
DTSTAMP:20250617T145719
DTSTART:20251024T150000
DTEND:20251024T160000
SUMMARY:DH 1.4  How drugs are used in hospitals
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:a563443e-546e-44c5-8c77-c610f208b93b
DTSTAMP:20250617T145719
DTSTART:20251027T100000
DTEND:20251027T110000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b8a153d6-2669-46a1-aef0-ef5f74260360
DTSTAMP:20250617T145719
DTSTART:20251027T110000
DTEND:20251027T120000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2b2e7b79-4709-43c7-9f5b-9fffa5b1598b
DTSTAMP:20250617T145719
DTSTART:20251027T120000
DTEND:20251027T130000
SUMMARY:Skills Routes of administration
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d9cb6b0a-a57e-4fa1-996a-a637906ee348
DTSTAMP:20250617T145719
DTSTART:20251027T140000
DTEND:20251027T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e33ef10d-a321-4e3f-96f3-13c92ecd6556
DTSTAMP:20250617T145719
DTSTART:20251027T150000
DTEND:20251027T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:172391c3-aae4-48dc-892c-45882ed2dbdb
DTSTAMP:20250617T145719
DTSTART:20251028T110000
DTEND:20251028T120000
SUMMARY:FS 1.16 Excitable Cells
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:f4452a5c-c6d5-46f1-8051-15d81fb2d3f0
DTSTAMP:20250617T145719
DTSTART:20251030T110000
DTEND:20251030T120000
SUMMARY:FS 1.14 Ion Channels
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:50c378f1-92b0-4c82-931c-a7c747e60169
DTSTAMP:20250617T145719
DTSTART:20251030T120000
DTEND:20251030T130000
SUMMARY:FS 1.15  LGICRs
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:f90eb9f8-375e-4f78-9813-89a6847f0b68
DTSTAMP:20250617T145719
DTSTART:20251030T140000
DTEND:20251030T150000
SUMMARY:PD 1.8 Drugs targenting ANS Part II - ANS scenarios
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:7228b2b9-84f6-4308-bdc7-4d5329a7bf76
DTSTAMP:20250617T145719
DTSTART:20251030T150000
DTEND:20251030T160000
SUMMARY:PK 1.4 Drug absorption
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:1eeb9aec-c1fa-4d01-87d1-5d8f77e5e679
DTSTAMP:20250617T145719
DTSTART:20251031T100000
DTEND:20251031T110000
SUMMARY:Presentation skills course groups 1&2 
NB. 10-1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2dc89398-0f6e-40a4-8f5f-0d572ef2c1a2
DTSTAMP:20250617T145719
DTSTART:20251031T110000
DTEND:20251031T120000
SUMMARY:DH Taking a drug history groups 3&4. 
NB 10-1
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:2b3c572f-15b2-4935-84bb-529756d0d084
DTSTAMP:20250617T145719
DTSTART:20251031T140000
DTEND:20251031T150000
SUMMARY:Team based learning 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:495db6d7-09c2-42d5-acce-b4cfbcdf7146
DTSTAMP:20250617T145719
DTSTART:20251031T150000
DTEND:20251031T160000
SUMMARY:Team based learning 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:561509be-9aa0-4cbb-a15b-a9a20507e865
DTSTAMP:20250617T145719
DTSTART:20251103T100000
DTEND:20251103T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:940ed4de-e5bb-4028-af07-bd99d7c59b5a
DTSTAMP:20250617T145719
DTSTART:20251103T110000
DTEND:20251103T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a3e1164a-4fba-4a96-95b1-646024946505
DTSTAMP:20250617T145719
DTSTART:20251103T120000
DTEND:20251103T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:c95e903c-8808-4656-8b7e-69814fd39833
DTSTAMP:20250617T145719
DTSTART:20251103T140000
DTEND:20251103T150000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7a80ebf2-3321-4509-8030-e8a5fef47ce6
DTSTAMP:20250617T145719
DTSTART:20251103T150000
DTEND:20251103T160000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:38ed3dc8-a997-475f-a59b-7599e5295885
DTSTAMP:20250617T145719
DTSTART:20251103T160000
DTEND:20251103T170000
SUMMARY:Skills 1.4 DNA practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:830cb2e2-dd10-42df-b03c-f162aa3c23d5
DTSTAMP:20250617T145719
DTSTART:20251104T110000
DTEND:20251104T120000
SUMMARY:FS 1.17 Skeletal muscle contraction and NMJ
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:47fc3b1c-7db0-4541-bc40-8a8ea52d710c
DTSTAMP:20250617T145719
DTSTART:20251104T120000
DTEND:20251104T130000
SUMMARY:FS 1.18 Smooth muscle contraction
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:86737a8b-44ae-442c-aca4-22aba9e4f137
DTSTAMP:20250617T145719
DTSTART:20251104T140000
DTEND:20251104T150000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:99b7c244-8d72-4b18-b31c-cdea018b1259
DTSTAMP:20250617T145719
DTSTART:20251104T150000
DTEND:20251104T160000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:69745621-4de2-46b1-81d9-8248c66f6a75
DTSTAMP:20250617T145719
DTSTART:20251105T100000
DTEND:20251105T110000
SUMMARY:WEC Pharmacy visits - Group 2 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:49cf27d0-5bca-4e33-8d99-f74510b92f87
DTSTAMP:20250617T145719
DTSTART:20251105T110000
DTEND:20251105T120000
SUMMARY:WEC Pharmacy visits - Group 2 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:910d9e46-157d-41cf-ac3a-c240564fc4f1
DTSTAMP:20250617T145719
DTSTART:20251106T110000
DTEND:20251106T120000
SUMMARY:FS recap Control and Regulation 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:e971e358-e6ac-4975-8f6c-c3539e6bae44
DTSTAMP:20250617T145719
DTSTART:20251106T120000
DTEND:20251106T130000
SUMMARY:FS recap Control and Regulation 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:8053fec3-b2e9-430c-89c4-db2c163cf441
DTSTAMP:20250617T145719
DTSTART:20251106T140000
DTEND:20251106T150000
SUMMARY:DS 1.4 Hypothesis testing
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:43b31b83-ce92-4a96-9664-24d4c968cb40
DTSTAMP:20250617T145719
DTSTART:20251106T150000
DTEND:20251106T160000
SUMMARY:DS Introduction to SPSS
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:287d724c-9aa9-4887-b47b-43db32a3f5f1
DTSTAMP:20250617T145719
DTSTART:20251106T160000
DTEND:20251106T170000
SUMMARY:DS Introduction to SPSS
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:e846ca56-ccf0-4723-add0-2998460e9efe
DTSTAMP:20250617T145719
DTSTART:20251107T100000
DTEND:20251107T110000
SUMMARY:Presentation skills course groups 1&2 
NB. 10-1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:46536659-0d29-46ee-846f-e68497a1dc06
DTSTAMP:20250617T145719
DTSTART:20251107T110000
DTEND:20251107T120000
SUMMARY:DH Taking a drug history groups 3&4. 
NB 10-1
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:6b7baf6e-adc2-4320-ba37-f492256b581d
DTSTAMP:20250617T145719
DTSTART:20251107T140000
DTEND:20251107T150000
SUMMARY:DD Introduction to clinical trials
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:48f2fe39-7794-471b-b155-5689fc1f0089
DTSTAMP:20250617T145719
DTSTART:20251107T150000
DTEND:20251107T160000
SUMMARY:DD Drug discovery in rare diseases
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:46f802c3-30d2-4419-9149-83e81f539ccf
DTSTAMP:20250617T145719
DTSTART:20251107T160000
DTEND:20251107T170000
SUMMARY:DD Drug discovery in rare diseases
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:6a39d995-5c9f-4a0c-875e-100c782ec641
DTSTAMP:20250617T145719
DTSTART:20251110T100000
DTEND:20251110T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b0f1d13f-ad6b-4d0a-a6d9-7f0802467abe
DTSTAMP:20250617T145719
DTSTART:20251110T110000
DTEND:20251110T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0e3fb4b1-148e-46a6-81d2-22678bfc6650
DTSTAMP:20250617T145719
DTSTART:20251110T120000
DTEND:20251110T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5318c16b-9432-4207-abdc-a7ea1fe4df8c
DTSTAMP:20250617T145719
DTSTART:20251110T140000
DTEND:20251110T150000
SUMMARY:Skills 1.5 Volume of distribution
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d73b873e-a02c-4dd9-9ee0-66359fe2e2d7
DTSTAMP:20250617T145719
DTSTART:20251110T150000
DTEND:20251110T160000
SUMMARY:Skills 1.5 Volume of distribution
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:65e8b827-6965-4618-90e9-41bed67fde0d
DTSTAMP:20250617T145719
DTSTART:20251111T120000
DTEND:20251111T130000
SUMMARY:Skills Measuring vital signs [briefing]
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:31ff1a90-3a4b-42ab-8b2f-07b2efd378f5
DTSTAMP:20250617T145719
DTSTART:20251111T130000
DTEND:20251111T140000
SUMMARY:PK 1.8 Volume of distribution
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:5d11a9df-6efb-41af-996a-bf579bb4d8e2
DTSTAMP:20250617T145719
DTSTART:20251111T140000
DTEND:20251111T150000
SUMMARY:PK Volume of distribution - introduction to calculations
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:4713eb0f-1284-4447-95ff-fdc7b8e3a4a2
DTSTAMP:20250617T145719
DTSTART:20251112T100000
DTEND:20251112T110000
SUMMARY:WEC Pharmacy visits - Group 3 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e9c6392d-6c8e-4401-ab57-3c3eb6a65e2c
DTSTAMP:20250617T145719
DTSTART:20251112T110000
DTEND:20251112T120000
SUMMARY:WEC Pharmacy visits - Group 3 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:746792d5-05c5-46b4-b87c-2af9a0bbd416
DTSTAMP:20250617T145719
DTSTART:20251113T100000
DTEND:20251113T110000
SUMMARY:Comms Course director/year lead check in 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0f5e79ad-e40d-4632-9996-06d9522c08ba
DTSTAMP:20250617T145719
DTSTART:20251113T110000
DTEND:20251113T120000
SUMMARY:FS 1.19 Body compartments and biological barriers 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:073be789-f63a-4377-a93f-04e2c35a73a1
DTSTAMP:20250617T145719
DTSTART:20251113T120000
DTEND:20251113T130000
SUMMARY:FS 1.20 Body compartments and biological barriers 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:99e54e7e-24d2-4eb3-9c08-203f40347e91
DTSTAMP:20250617T145719
DTSTART:20251113T140000
DTEND:20251113T150000
SUMMARY:DS 1.5 Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:bd09eba0-b9db-487f-be27-1393c1eaed9f
DTSTAMP:20250617T145719
DTSTART:20251113T150000
DTEND:20251113T160000
SUMMARY:DS Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:bf034e76-3083-44c5-9a29-773b271102fd
DTSTAMP:20250617T145719
DTSTART:20251113T160000
DTEND:20251113T170000
SUMMARY:DS  Descriptive vs inferential statistics
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:bdc9a987-6533-4973-8692-2d25945453fe
DTSTAMP:20250617T145719
DTSTART:20251114T100000
DTEND:20251114T110000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:b5bce052-7425-4163-9219-549c9d15c4a1
DTSTAMP:20250617T145719
DTSTART:20251114T110000
DTEND:20251114T120000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:4bda3835-ed14-4b86-b645-a4672f45db70
DTSTAMP:20250617T145719
DTSTART:20251114T120000
DTEND:20251114T130000
SUMMARY:Comms Wellbeing - looking after ourselves
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8702469a-d8c7-459b-bb88-936357c5ce15
DTSTAMP:20250617T145719
DTSTART:20251114T140000
DTEND:20251114T150000
SUMMARY:PD Recap workshop
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:7fa3607b-c87d-4ef4-8295-714e87615cd4
DTSTAMP:20250617T145719
DTSTART:20251114T150000
DTEND:20251114T160000
SUMMARY:PD Recap workshop
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:9b9a60bd-e8e5-4823-898f-9e261b75724c
DTSTAMP:20250617T145719
DTSTART:20251117T100000
DTEND:20251117T110000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:af8d0720-aecf-406f-88fd-00dc6e0df7b9
DTSTAMP:20250617T145719
DTSTART:20251117T110000
DTEND:20251117T120000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4dc1baba-b16e-42da-8a82-1a5f93c634f5
DTSTAMP:20250617T145719
DTSTART:20251117T120000
DTEND:20251117T130000
SUMMARY:Skills Measuring vital signs
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:14f8ce31-eaa8-4148-b34b-89465ae941c1
DTSTAMP:20250617T145719
DTSTART:20251117T140000
DTEND:20251117T150000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f57e2e0d-ad3c-4984-b2f0-1b38ad2a9bab
DTSTAMP:20250617T145719
DTSTART:20251117T150000
DTEND:20251117T160000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9a5915d7-9066-4477-8e9b-3cef54033838
DTSTAMP:20250617T145719
DTSTART:20251118T140000
DTEND:20251118T150000
SUMMARY:Skills Dissection 1. Liver and kidney
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:db8d5abd-d4c1-46b2-a7a5-2a22fcf6fe7d
DTSTAMP:20250617T145719
DTSTART:20251118T150000
DTEND:20251118T160000
SUMMARY:Dissection 1. Liver and kidney
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ed83707e-198b-416a-bd87-6ba14cfc11ca
DTSTAMP:20250617T145719
DTSTART:20251119T100000
DTEND:20251119T110000
SUMMARY:WEC Pharmacy visits - Group 4 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:16ceaa10-b684-41de-ad20-6ec23ca8905e
DTSTAMP:20250617T145719
DTSTART:20251119T110000
DTEND:20251119T120000
SUMMARY:WEC Pharmacy visits - Group 4 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6a88a5c9-8c7e-44cd-95d3-d3f8884f3acf
DTSTAMP:20250617T145719
DTSTART:20251120T100000
DTEND:20251120T110000
SUMMARY:FS 1.21 Liver structure and function
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:5d4084a8-6245-4e5e-add1-76f791c01ce3
DTSTAMP:20250617T145719
DTSTART:20251120T110000
DTEND:20251120T120000
SUMMARY:FS 1.22 Liver structure and function
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:944c0203-684c-4974-978a-5ae44b2c6342
DTSTAMP:20250617T145719
DTSTART:20251120T120000
DTEND:20251120T130000
SUMMARY:PK 1.7 Drug metabolism by the liver 1
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:83993e26-7fc5-4653-8d4c-cfce37efc801
DTSTAMP:20250617T145719
DTSTART:20251120T140000
DTEND:20251120T150000
SUMMARY:DS term 1 - pulling it all together
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:4cde43e3-8689-40b5-82bc-356b4545ef75
DTSTAMP:20250617T145719
DTSTART:20251120T150000
DTEND:20251120T160000
SUMMARY:DS Liver adverse drug reaction analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:8c1d7ca5-146e-400c-ac9c-afe197f02ef5
DTSTAMP:20250617T145719
DTSTART:20251120T160000
DTEND:20251120T170000
SUMMARY:DS  Liver adverse drug reaction analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:99d9eb80-0b9d-4782-a984-1dc927b4c2c5
DTSTAMP:20250617T145719
DTSTART:20251121T110000
DTEND:20251121T120000
SUMMARY:DD Science techniques
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:b987e043-1427-46f6-a16f-a9c9c0bdb628
DTSTAMP:20250617T145719
DTSTART:20251121T120000
DTEND:20251121T130000
SUMMARY:DD Science techniques
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:c1761f59-0455-42f5-aa40-be6ce4fdac2c
DTSTAMP:20250617T145719
DTSTART:20251121T140000
DTEND:20251121T150000
SUMMARY:Team based learning 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2f11c702-2d8b-46c3-99fe-c1e93a299f4c
DTSTAMP:20250617T145719
DTSTART:20251121T150000
DTEND:20251121T160000
SUMMARY:Team based learning 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0f1f7f0f-942c-47eb-b96b-7bbf8f3bc813
DTSTAMP:20250617T145719
DTSTART:20251124T100000
DTEND:20251124T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:451ca0b5-95fc-496e-9236-fef7d1ef4273
DTSTAMP:20250617T145719
DTSTART:20251124T110000
DTEND:20251124T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b6b4eac7-c300-49ea-8ce3-c3905d1cb66b
DTSTAMP:20250617T145719
DTSTART:20251124T120000
DTEND:20251124T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8600d240-a229-4a4f-ac7c-5c975fb718b1
DTSTAMP:20250617T145719
DTSTART:20251124T140000
DTEND:20251124T150000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:bc4ec0bd-7b5c-4b7a-b77f-5e59e6f1b13e
DTSTAMP:20250617T145719
DTSTART:20251124T150000
DTEND:20251124T160000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a273bfd0-7ea8-4451-b156-a0d88372a101
DTSTAMP:20250617T145719
DTSTART:20251124T160000
DTEND:20251124T170000
SUMMARY:Skills 1.7  Spectrophotometry 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1d9aa86a-505f-47ef-9565-33670f52f9c1
DTSTAMP:20250617T145719
DTSTART:20251125T110000
DTEND:20251125T120000
SUMMARY:FS 1.23 Structure and function of the kidney
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:80ac71f4-cdc6-47a8-bea1-3ae6b5aa0de4
DTSTAMP:20250617T145719
DTSTART:20251125T120000
DTEND:20251125T130000
SUMMARY:FS 1.23 Structure and function of the kidney
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:9c413787-f7cb-4101-ab2c-adb29d9cfc25
DTSTAMP:20250617T145719
DTSTART:20251126T100000
DTEND:20251126T110000
SUMMARY:WEC Pharmacy visits - Group 5 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:da9d4e15-3e34-4400-974b-d2dcdecf20ec
DTSTAMP:20250617T145719
DTSTART:20251126T110000
DTEND:20251126T120000
SUMMARY:WEC Pharmacy visits - Group 5 (7 students)
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d2b0b3b1-85ce-4b2f-85cf-c7d9ef048389
DTSTAMP:20250617T145719
DTSTART:20251127T110000
DTEND:20251127T120000
SUMMARY:PK 1.9 Drug excretion including renal elimination
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:938afed0-3d4b-4f43-afd7-6d36bb3e5052
DTSTAMP:20250617T145719
DTSTART:20251127T120000
DTEND:20251127T130000
SUMMARY:PK 1.10 Drug clearance
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:96ac3192-b0c7-4a1d-a5af-f504bcde8e27
DTSTAMP:20250617T145719
DTSTART:20251127T140000
DTEND:20251127T150000
SUMMARY:PK Joint workshop with fundamentals of science
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:d671b678-e21c-4074-8e0c-4bac688bc84f
DTSTAMP:20250617T145719
DTSTART:20251127T150000
DTEND:20251127T160000
SUMMARY:FS Joint workshop with pharmacokinetics
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:14f4cf92-b9ca-4508-b450-691db5bca79d
DTSTAMP:20250617T145719
DTSTART:20251128T110000
DTEND:20251128T120000
SUMMARY:DH 1.5 Therapeutic journey from prescription to outcome
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:d54b70c2-02e2-4806-9232-d214c7ad85c7
DTSTAMP:20250617T145719
DTSTART:20251128T120000
DTEND:20251128T130000
SUMMARY:DH 1.5 Therapeutic journey from prescription to outcome
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:fc52b81c-f100-4e59-879a-8b66e3fa4cd2
DTSTAMP:20250617T145719
DTSTART:20251128T140000
DTEND:20251128T150000
SUMMARY:PK Recap and review
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:418a2942-6540-4a99-af69-90266f5840be
DTSTAMP:20250617T145719
DTSTART:20251128T150000
DTEND:20251128T160000
SUMMARY:PK Recap and review
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:ca641dc1-415a-4798-a5bd-9dca363f0043
DTSTAMP:20250617T145719
DTSTART:20251208T140000
DTEND:20251208T150000
SUMMARY:Assess Big quiz 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:18a7f5e2-54b1-4948-9e0d-3e5e1bd4b375
DTSTAMP:20250617T145719
DTSTART:20251208T150000
DTEND:20251208T160000
SUMMARY:Assess Big quiz 1
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:479d65b1-f0ac-4099-83f1-4b39b72aad24
DTSTAMP:20250617T145719
DTSTART:20251208T160000
DTEND:20251208T170000
SUMMARY:Christmas social
DESCRIPTION:Non-modular
END:VEVENT
BEGIN:VEVENT
UID:06beb4cb-7ca7-4dd9-be61-b4e1b6ce0374
DTSTAMP:20250617T145719
DTSTART:20260105T100000
DTEND:20260105T110000
SUMMARY:HUB NB Need computer lab too for Assess BQ1 resits
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7779bc4b-e054-4c10-a14a-4399e7ff201b
DTSTAMP:20250617T145719
DTSTART:20260105T110000
DTEND:20260105T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:74d1ce64-c104-457b-8295-2cd5b0679b77
DTSTAMP:20250617T145719
DTSTART:20260105T120000
DTEND:20260105T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:0fa65b19-f714-4e4c-ad32-2eb63ae77cae
DTSTAMP:20250617T145719
DTSTART:20260105T140000
DTEND:20260105T150000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:e6b358d9-3e00-4c38-8665-62170bf7f1f1
DTSTAMP:20250617T145719
DTSTART:20260105T150000
DTEND:20260105T160000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:d7d4a526-071b-48b9-9e49-46186850c7ca
DTSTAMP:20250617T145719
DTSTART:20260106T110000
DTEND:20260106T120000
SUMMARY:FS 1.27 Immunity 1
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:c8a461ac-3f89-49e3-9243-ec5310a1f6d7
DTSTAMP:20250617T145719
DTSTART:20260106T120000
DTEND:20260106T130000
SUMMARY:FS 1.28 Immunity 2
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:fc975445-584c-4b91-91c8-f09ae15fa37b
DTSTAMP:20250617T145719
DTSTART:20260108T100000
DTEND:20260108T110000
SUMMARY:Comms Course director/year lead check in 2
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:a63cb2f9-1153-44f5-bb80-87d92d6e9baa
DTSTAMP:20250617T145719
DTSTART:20260108T110000
DTEND:20260108T120000
SUMMARY:FS 1.29 Structure and function of blood
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:0c91a328-3a85-4655-a718-688e5880aa9e
DTSTAMP:20250617T145719
DTSTART:20260108T120000
DTEND:20260108T130000
SUMMARY:FS 1.30 Blood disorders
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:2782b9b8-b4ab-4fe0-9a60-f0c635fc76ca
DTSTAMP:20250617T145719
DTSTART:20260108T140000
DTEND:20260108T150000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:a71a9982-7d82-47b0-9415-90db6e15864b
DTSTAMP:20250617T145719
DTSTART:20260108T150000
DTEND:20260108T160000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:609d63b4-475d-4676-be8b-cb4a4867fbc1
DTSTAMP:20250617T145719
DTSTART:20260108T160000
DTEND:20260108T170000
SUMMARY:DS 1.7 Comparing and visualising quantitative data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:c8546f4c-4f65-4b79-b83e-5833479727de
DTSTAMP:20250617T145719
DTSTART:20260109T100000
DTEND:20260109T110000
SUMMARY:DD Designing a clinical study
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:f53cc4cb-3716-4bd2-81ac-66a188b5089c
DTSTAMP:20250617T145719
DTSTART:20260109T110000
DTEND:20260109T120000
SUMMARY:DD Designing a clinical study
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:1a267698-4986-4917-971f-2ab7182af83f
DTSTAMP:20250617T145719
DTSTART:20260109T120000
DTEND:20260109T130000
SUMMARY:DD Briefing on handling biological samples (urine) for aspirin practical
DESCRIPTION:PHA404
END:VEVENT
BEGIN:VEVENT
UID:a5363d0e-94d2-4c63-819f-15d111b421a6
DTSTAMP:20250617T145719
DTSTART:20260109T140000
DTEND:20260109T150000
SUMMARY:PD 2.13 Anti-platelet and fibrinolytic agents
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:82c970e1-a365-4741-9dc7-46299043fcfa
DTSTAMP:20250617T145719
DTSTART:20260109T150000
DTEND:20260109T160000
SUMMARY:DH 2.9 Platelets as drug targets - arterial thrombosis
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:b8da9a33-46d8-4598-898a-32ad0fa15b63
DTSTAMP:20250617T145719
DTSTART:20260112T100000
DTEND:20260112T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5953bfd0-b44f-4c79-afd0-90d1f89d1b29
DTSTAMP:20250617T145719
DTSTART:20260112T110000
DTEND:20260112T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f5257b66-a47a-47b3-bd49-a62d5b6aefd2
DTSTAMP:20250617T145719
DTSTART:20260112T120000
DTEND:20260112T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:3c55b6ae-1ccd-4d7c-b02f-120dd4c47fb3
DTSTAMP:20250617T145719
DTSTART:20260112T140000
DTEND:20260112T150000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:314a1ff7-58e8-4c71-923d-63ea407d4961
DTSTAMP:20250617T145719
DTSTART:20260112T150000
DTEND:20260112T160000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7d30d61d-3158-4838-a30c-44917b4fea62
DTSTAMP:20250617T145719
DTSTART:20260112T160000
DTEND:20260112T170000
SUMMARY:Skills 1.11  Spectrophotometry 3. 
Aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7920da64-702a-49c4-9058-03a8e99e7af2
DTSTAMP:20250617T145719
DTSTART:20260113T120000
DTEND:20260113T130000
SUMMARY:Skills Writing up the aspirin practical
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:147360a1-6c32-4540-b410-5b5dade196a9
DTSTAMP:20250617T145719
DTSTART:20260113T140000
DTEND:20260113T150000
SUMMARY:FS 2.14  Blood Coagulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:06647f67-b964-42f7-a0dd-319555fcaa70
DTSTAMP:20250617T145719
DTSTART:20260113T150000
DTEND:20260113T160000
SUMMARY:FS 2.15 Blood Coagulation
DESCRIPTION:PHA401
END:VEVENT
BEGIN:VEVENT
UID:dcdb18ad-b4a9-4250-aa70-6ed3dbe55206
DTSTAMP:20250617T145719
DTSTART:20260115T100000
DTEND:20260115T110000
SUMMARY:Comms - introduction to literature searching
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9f230b40-564c-4636-a045-fa8a177a3b25
DTSTAMP:20250617T145719
DTSTART:20260115T110000
DTEND:20260115T120000
SUMMARY:PD 2.14  Anticoagulants
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:d3ce1b57-4ee8-444f-8f5d-c63481c848c1
DTSTAMP:20250617T145719
DTSTART:20260115T120000
DTEND:20260115T130000
SUMMARY:PD 2.15 Anticoagulants
DESCRIPTION:PHA402
END:VEVENT
BEGIN:VEVENT
UID:806eefba-6721-4f60-8a16-de6a971d4819
DTSTAMP:20250617T145719
DTSTART:20260115T140000
DTEND:20260115T150000
SUMMARY:DH 1.6 How is the NHS structured?
DESCRIPTION:PHA405
END:VEVENT
BEGIN:VEVENT
UID:94bdeeb4-3c0b-4f03-913a-b3cc91a36a16
DTSTAMP:20250617T145719
DTSTART:20260115T150000
DTEND:20260115T160000
SUMMARY:PK 1.12 Therapeutic drug monitoring
DESCRIPTION:PHA403
END:VEVENT
BEGIN:VEVENT
UID:316efbf8-d639-430f-a373-4bb0102bd6c0
DTSTAMP:20250617T145719
DTSTART:20260116T100000
DTEND:20260116T110000
SUMMARY:DS 1.8 Comparing and visualising categorical data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:e98e3529-8f98-4648-a58d-d17bd916b2d3
DTSTAMP:20250617T145719
DTSTART:20260116T110000
DTEND:20260116T120000
SUMMARY:DS 1.8 Comparing and visualising categorical data
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:c1fe3f4e-36ee-41fc-8433-f12f2c38bcb5
DTSTAMP:20250617T145719
DTSTART:20260116T120000
DTEND:20260116T130000
SUMMARY:DS  Aspirin practical analysis
DESCRIPTION:PHA406
END:VEVENT
BEGIN:VEVENT
UID:7743985f-05ad-44c4-abce-819b84ec6f34
DTSTAMP:20250617T145719
DTSTART:20260116T140000
DTEND:20260116T150000
SUMMARY:DBL Karen Jones
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:202e5613-417d-4ca3-a8c6-4e840ebabb30
DTSTAMP:20250617T145719
DTSTART:20260116T150000
DTEND:20260116T160000
SUMMARY:DBL Karen Jones
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:75c1235d-64b6-4493-b8a1-9774e092a662
DTSTAMP:20250617T145719
DTSTART:20260119T100000
DTEND:20260119T110000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dbbc2621-38f0-4b1b-a7cb-2c167d246715
DTSTAMP:20250617T145719
DTSTART:20260119T110000
DTEND:20260119T120000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:044c8be2-d6a0-4986-8201-bd4abf50adcc
DTSTAMP:20250617T145719
DTSTART:20260119T120000
DTEND:20260119T130000
SUMMARY:HUB
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ac7c1bf6-a38a-4910-ad14-f7fd7fb87f9e
DTSTAMP:20250617T145719
DTSTART:20260119T140000
DTEND:20260119T150000
SUMMARY:Dragon's den poster drop in
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2c51cf8f-80b9-400e-a41d-825ab1d52594
DTSTAMP:20250617T145719
DTSTART:20260119T150000
DTEND:20260119T160000
SUMMARY:Dragon's den poster drop in
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:e556de00-5179-4342-b7f6-231dd7ab1e44
DTSTAMP:20250617T145719
DTSTART:20260120T100000
DTEND:20260120T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:ee79ef14-95a3-4157-82d7-0a9f24ef492c
DTSTAMP:20250617T145719
DTSTART:20260120T110000
DTEND:20260120T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5248e485-6493-482e-b888-4f1895c6fb68
DTSTAMP:20250617T145719
DTSTART:20260120T120000
DTEND:20260120T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:658e93e6-1486-4531-b076-0f4b1be48af0
DTSTAMP:20250617T145719
DTSTART:20260120T130000
DTEND:20260120T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:111e7c4d-1b24-426b-a681-40776fa89ef8
DTSTAMP:20250617T145719
DTSTART:20260120T140000
DTEND:20260120T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:809dd222-b0c9-404a-bd66-4c0dc79ef96e
DTSTAMP:20250617T145719
DTSTART:20260120T150000
DTEND:20260120T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:76677181-1cf7-4e6e-b344-897c5dd917be
DTSTAMP:20250617T145719
DTSTART:20260120T160000
DTEND:20260120T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4bf4a825-ab80-44b2-84b1-96418977ece8
DTSTAMP:20250617T145719
DTSTART:20260121T100000
DTEND:20260121T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:cfd2947d-2448-4f06-80f6-8e6a0802a89d
DTSTAMP:20250617T145719
DTSTART:20260121T110000
DTEND:20260121T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f93fb69e-e8b0-497c-b5ac-8abf0b4bb51f
DTSTAMP:20250617T145719
DTSTART:20260121T120000
DTEND:20260121T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4597a6b0-0515-40f8-a678-5ae9daaaa0a7
DTSTAMP:20250617T145719
DTSTART:20260121T130000
DTEND:20260121T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:eeba48c3-8e4a-4e0d-9411-2ee0fc7d23ae
DTSTAMP:20250617T145719
DTSTART:20260121T140000
DTEND:20260121T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:9b9733c7-ae59-48be-a48c-8e47cfbb465c
DTSTAMP:20250617T145719
DTSTART:20260121T150000
DTEND:20260121T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:679daadb-a798-4e2a-8c1b-2f6859e319e1
DTSTAMP:20250617T145719
DTSTART:20260121T160000
DTEND:20260121T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5f961541-033f-4834-891d-8ed32b4baa0e
DTSTAMP:20250617T145719
DTSTART:20260122T100000
DTEND:20260122T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:15c001d9-d61d-4323-aa69-43a9890c850a
DTSTAMP:20250617T145719
DTSTART:20260122T110000
DTEND:20260122T120000
SUMMARY:Aspirin practical drop in help on teams
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:dab0b0e7-a31f-4a57-a105-c565198ebaf9
DTSTAMP:20250617T145719
DTSTART:20260122T120000
DTEND:20260122T130000
SUMMARY:Aspirin practical drop in help on teams
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4ac65f32-d1c1-45a3-83d7-bd70518a5b9a
DTSTAMP:20250617T145719
DTSTART:20260122T140000
DTEND:20260122T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:8201f0e1-6a51-4c77-b56f-e2e890605915
DTSTAMP:20250617T145719
DTSTART:20260122T150000
DTEND:20260122T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:5ccdd2cf-b58d-4031-890b-a3376ac9fd07
DTSTAMP:20250617T145719
DTSTART:20260122T160000
DTEND:20260122T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:6cbf57e0-762a-4ca1-bac0-291153a49b72
DTSTAMP:20250617T145719
DTSTART:20260123T100000
DTEND:20260123T110000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:fc58b86b-d33a-4f45-981c-f69667a8f802
DTSTAMP:20250617T145719
DTSTART:20260123T110000
DTEND:20260123T120000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4323cdee-61c1-464e-844e-591d764a17e8
DTSTAMP:20250617T145719
DTSTART:20260123T120000
DTEND:20260123T130000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d33bad0e-1a6f-413a-a429-712202bb94d1
DTSTAMP:20250617T145719
DTSTART:20260123T130000
DTEND:20260123T140000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f95d7519-9c71-4e73-895a-65199cafb031
DTSTAMP:20250617T145719
DTSTART:20260123T140000
DTEND:20260123T150000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:2ab5ceca-31c1-4be8-8f49-948e98d8673e
DTSTAMP:20250617T145719
DTSTART:20260123T150000
DTEND:20260123T160000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:4f0320da-8439-45a9-a376-a30f1b6c611e
DTSTAMP:20250617T145719
DTSTART:20260123T160000
DTEND:20260123T170000
SUMMARY:Aspirin practical write up
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:7b522198-7ceb-4b78-904c-46545dd1bfa6
DTSTAMP:20250617T145719
DTSTART:20260129T140000
DTEND:20260129T150000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:56e5f214-b2ff-45e6-b223-4e5055a7473a
DTSTAMP:20250617T145719
DTSTART:20260129T150000
DTEND:20260129T160000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:58736753-1a9e-49bd-af08-6d74f709e442
DTSTAMP:20250617T145719
DTSTART:20260129T160000
DTEND:20260129T170000
SUMMARY:Dragons' den practice
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:217f91a0-60c8-4d78-b603-f6f58ebc9c49
DTSTAMP:20250617T145719
DTSTART:20260130T100000
DTEND:20260130T110000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:d493330c-4a7b-40eb-ad2b-7a6a904e9e0d
DTSTAMP:20250617T145719
DTSTART:20260130T110000
DTEND:20260130T120000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:f68caa04-28a1-48ae-a022-6b086e18899c
DTSTAMP:20250617T145719
DTSTART:20260130T120000
DTEND:20260130T130000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:acebc832-7825-466a-b95e-38b044bb7171
DTSTAMP:20250617T145719
DTSTART:20260130T140000
DTEND:20260130T150000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:1059d435-754d-4d4f-affe-d195f144106b
DTSTAMP:20250617T145719
DTSTART:20260130T150000
DTEND:20260130T160000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
BEGIN:VEVENT
UID:b4e57722-8eaf-4aae-97f2-f990038cfe4b
DTSTAMP:20250617T145719
DTSTART:20260130T160000
DTEND:20260130T170000
SUMMARY:Dragon's Den
DESCRIPTION:PHA407
END:VEVENT
END:VCALENDAR
